drugset / Trial / NCT04372355
Effect of WF10 (TCDO) on HbA1c Values in Diabetic Foot Ulcer Patients
Phase 2
Completed
40 enrolled
Srinakharinwirot University
Altermed Co.,Ltd. · collabOxo Chemie(Thailand) Co.,Ltd. · collab
NaSingle-groupOpen-labelTreatment
Summary
Study in adult Diabetes Mellitus patients with diabetic foot ulcers and elevated HbA1c who will receive standard wound treatment in combination with adjuvant therapy WF10 to compare the change of HbA1c levels at baseline and after treatment.
Timeline
- Start
- 2019-06-19
- Primary completion
- 2020-04-30
- Completion
- 2020-06-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | WF10 | Other / unclassified | 0.3 unknown | Intravenous |